Table 1. Baseline Participant Characteristics for Phase 1 and Phase 2.
| PHASE 1 | Randomized pre-cessation conditions | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nicotine Patch | Bupropion+Nicotine Patch | Varenicline | |||||||
|
|
|||||||||
| Gender (male) | n (%) | 51 | (48.1) | 53 | (53.5) | 62 | (60.2) | ||
| 21 mg nicotine patch | n (%) | 70 | (66.0) | 64 | (64.6) | 69 | (66.9) | ||
| Menthol cigarette brand | n (%) | 55 | (51.9) | 49 | (49.5) | 52 | (50.5) | ||
| Cigarettes/day | mean (SD) | 21.3 | (8.9) | 21.9 | (8.8) | 21.8 | (10.6) | ||
| Age | mean (SD) | 44.3 | (10.8) | 46.0 | (10.8) | 44.7 | (10.7) | ||
| Years smoked | mean (SD) | 26.0 | (11.2) | 26.8 | (10.6) | 25.9 | (11.0) | ||
| FTND score | mean (SD) | 5.8 | (2.0) | 5.8 | (2.0) | 5.8 | (1.7) | ||
| End-expired air CO | mean (SD) | 28.6 | (14.1) | 28.5 | (11.6) | 28.9 | (11.5) | ||
| Cotinine (ng/mL) | mean (SD) | 346 | (214) | 366 | (189) | 359 | (218) | ||
| Race/ethnicity | |||||||||
| European-American | n (%) | 67 | (63.2) | 61 | (61.6) | 66 | (64.1) | ||
| African-American | n (%) | 34 | (32.1) | 27 | (27.3) | 34 | (33.0) | ||
| Other | n (%) | 5 | (4.7) | 11 | (11.1) | 3 | (2.9) | ||
| PHASE 2 | Randomized post-cessation conditions | ||||||||
| Nicotine Patch | Bupropion+Nicotine Patch | Varenicline | Open-label Nicotine Patch | ||||||
| Gender (male) | n (%) | 11 | (36.7) | 15 | (50.0) | 18 | (51.4) | 60 | (50.0) |
| 21 mg nicotine patch | n (%) | 14 | (46.7) | 13 | (43.3) | 15 | (42.9) | 57 | (47.5) |
| Menthol cigarette brand | n (%) | 16 | (53.3) | 12 | (40.0) | 16 | (45.7) | 50 | (41.7) |
| Cigarettes/day | mean (SD) | 19.1 | (9.2) | 22.9 | (10.5) | 20.5 | (8.2) | 20.8 | (7.4) |
| Age | mean (SD) | 40.8 | (12.8) | 43.1 | (11.6) | 44.1 | (11.2) | 43.5 | (10.1) |
| Years smoked | mean (SD) | 22.7 | (12.0) | 24.7 | (11.4) | 24.6 | (10.5) | 24.6 | (10.3) |
| FTND score | mean (SD) | 5.7 | (1.9) | 6.3 | (2.0) | 5.9 | (2.3) | 5.6 | (1.6) |
| End-expired air CO | mean (SD) | 26.8 | (13.4) | 28.9 | (8.6) | 27.9 | (12.7) | 30.2 | (12.4) |
| Cotinine (ng/mL) | mean (SD) | 334 | (189) | 369 | (237) | 339 | (235) | 384 | (214) |
| Race/ethnicity | |||||||||
| European-American | n (%) | 18 | (60.0) | 20 | (66.7) | 21 | (60.0) | 89 | (74.2) |
| African-American | n (%) | 11 | (36.7) | 8 | (26.7) | 14 | (40.0) | 25 | (20.8) |
| Other | n (%) | 1 | (3.3) | 2 | (6.7) | 0 | (0.0) | 6 | (5.0) |